Expansion of the global antibiotics market size
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
List view / Grid view
News
GORE™ ImproJect™ Plunger for pre-filled syringes at Pharmapack Europe
Gore, a global materials science company, attends Pharmapack Europe to continue their year-long launch of the GORE™ ImproJect™ Plunger for pre-filled syringes...
Brilinta shows promise in phase III clinical trial
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
BPSA releases guide to production of cell and gene therapies
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper...
Danaher acquires GE biopharma for $21.4 billion
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
European Medicines Agency forced to pay London lease
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
Blockchain could help ensure clinical trial integrity
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
Utilising electric car batteries for safer and cheaper medicine manufacture
A method commonly used in lithium-ion batteries has been developed to help the safer and cheaper manufacture of medicines...
EU measures in support of generic pharmaceuticals producers
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
‘Smart drug’ shows promise for metastatic triple-negative breast cancer
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
Structural barriers biggest reason for low participation in clinical trials
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
Inadequate FDA oversight concerning fentanyl prescriptions
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
Oral antifungals used to treat yeast infections could lead to miscarriage
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
Drug combination may become new standard treatment for advanced kidney cancer
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment...
